JP2021046422A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021046422A5 JP2021046422A5 JP2020200176A JP2020200176A JP2021046422A5 JP 2021046422 A5 JP2021046422 A5 JP 2021046422A5 JP 2020200176 A JP2020200176 A JP 2020200176A JP 2020200176 A JP2020200176 A JP 2020200176A JP 2021046422 A5 JP2021046422 A5 JP 2021046422A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- steps
- reacting
- prepared
- react
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 70
- 238000000034 method Methods 0.000 claims 38
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 6
- BEOOHQFXGBMRKU-UHFFFAOYSA-N Sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 claims 6
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims 6
- CWMFRHBXRUITQE-UHFFFAOYSA-N Trimethylsilylacetylene Chemical group C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 claims 4
- 238000010276 construction Methods 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000011780 sodium chloride Substances 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 3
- ROADCYAOHVSOLQ-UHFFFAOYSA-N 3-Oxetanone Chemical compound O=C1COC1 ROADCYAOHVSOLQ-UHFFFAOYSA-N 0.000 claims 2
- MKRTXPORKIRPDG-UHFFFAOYSA-N Diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 claims 2
- WMFOQBRAJBCJND-UHFFFAOYSA-M lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N t-BuOH Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims 2
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 2
- XWZOKATWICIEMU-UHFFFAOYSA-N (3,5-difluoro-4-formylphenyl)boronic acid Chemical compound OB(O)C1=CC(F)=C(C=O)C(F)=C1 XWZOKATWICIEMU-UHFFFAOYSA-N 0.000 claims 1
- WAPNOHKVXSQRPX-ZETCQYMHSA-N (S)-1-phenylethanol Chemical compound C[C@H](O)C1=CC=CC=C1 WAPNOHKVXSQRPX-ZETCQYMHSA-N 0.000 claims 1
- WSZRCNZXKKTLQE-UHFFFAOYSA-N 2-chloro-5-iodopyrimidine Chemical compound ClC1=NC=C(I)C=N1 WSZRCNZXKKTLQE-UHFFFAOYSA-N 0.000 claims 1
- GYZNHUNWABYAPO-UHFFFAOYSA-N 2-fluoro-5-iodopyridine Chemical compound FC1=CC=C(I)C=N1 GYZNHUNWABYAPO-UHFFFAOYSA-N 0.000 claims 1
- 125000006306 4-iodophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1I 0.000 claims 1
- XHZWFUVEKDDQPF-UHFFFAOYSA-N 5-bromo-1H-pyrazole Chemical compound BrC1=CC=NN1 XHZWFUVEKDDQPF-UHFFFAOYSA-N 0.000 claims 1
- TXYRJHDLEIIQLT-UHFFFAOYSA-N 5-tert-butyl-3,8-diazabicyclo[3.2.1]octane-8-carboxylic acid Chemical compound C1NCC2CCC1(C(C)(C)C)N2C(O)=O TXYRJHDLEIIQLT-UHFFFAOYSA-N 0.000 claims 1
- AUPXBVDHVRZMIB-UHFFFAOYSA-M C[Mg]I Chemical compound C[Mg]I AUPXBVDHVRZMIB-UHFFFAOYSA-M 0.000 claims 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atoms Chemical class [H]* 0.000 claims 1
- UAVOCTDYPKOULU-UHFFFAOYSA-N methylchloranuidyl formate Chemical compound C[Cl-]OC=O UAVOCTDYPKOULU-UHFFFAOYSA-N 0.000 claims 1
- HNINFCBLGHCFOJ-UHFFFAOYSA-N tert-butyl 3,8-diazabicyclo[3.2.1]octane-8-carboxylate Chemical compound C1NCC2CCC1N2C(=O)OC(C)(C)C HNINFCBLGHCFOJ-UHFFFAOYSA-N 0.000 claims 1
- DKACXUFSLUYRFU-UHFFFAOYSA-N tert-butyl N-aminocarbamate Chemical compound CC(C)(C)OC(=O)NN DKACXUFSLUYRFU-UHFFFAOYSA-N 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 0 CC(*(C=C1)*=C1c1cc(N)c(C*(C[C@@]([C@](Cc2ccc(C)cc2)*(C)(C)O)OC)*(C)*)c(N)c1)N Chemical compound CC(*(C=C1)*=C1c1cc(N)c(C*(C[C@@]([C@](Cc2ccc(C)cc2)*(C)(C)O)OC)*(C)*)c(N)c1)N 0.000 description 2
- TYQRGOIPUSJXNX-ZCFIWIBFSA-N CC(C)(C)OC(N[C@@H](C(C)(C)C(F)(F)F)C(O)=O)=O Chemical compound CC(C)(C)OC(N[C@@H](C(C)(C)C(F)(F)F)C(O)=O)=O TYQRGOIPUSJXNX-ZCFIWIBFSA-N 0.000 description 1
- POSMOHKERVVHFN-SCSAIBSYSA-N CC(C)([C@@H](C(O)=O)NC(OC)=O)C(F)(F)F Chemical compound CC(C)([C@@H](C(O)=O)NC(OC)=O)C(F)(F)F POSMOHKERVVHFN-SCSAIBSYSA-N 0.000 description 1
- UAUWOBGBRCGFGR-UHFFFAOYSA-N Ic1ccc(N2CC(CC3)N(C4COC4)C3C2)nc1 Chemical compound Ic1ccc(N2CC(CC3)N(C4COC4)C3C2)nc1 UAUWOBGBRCGFGR-UHFFFAOYSA-N 0.000 description 1
Claims (18)
- 3−ブロモ−1H−ピラゾールを3,5−ジフルオロ−4−ホルミルフェニルボロン酸と反応させるステップを含む、化合物P4を調製するプロセス。
- 請求項17に記載のプロセスであって、脱保護された化合物A1が、
a)化合物A1a:
をメチルマグネシウムヨージドと反応させて、化合物A1b:
を提供するステップ、
b)化合物A1bをNaOHと反応させて、化合物A1c:
を提供するステップ、
c)化合物A1cをジフェニルホスホリルアジド(DPPA)、トリエチルアミンおよびt−BuOHと反応させて、化合物A1d:
を提供するステップ、
d)化合物A1dをLiOHと反応させて、化合物A1e:
を提供するステップ、
e)化合物A1eを(S)−(−)−1−フェニルエタノールとカップリングさせて、化合物A1f:
を提供するステップ、
f)化合物A1fを水素と反応させて、化合物A1:
を提供するステップ、ならびに
g)化合物A1をHClで脱保護するステップ
を含むプロセスによって調製される、プロセス。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762455348P | 2017-02-06 | 2017-02-06 | |
US62/455,348 | 2017-02-06 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019542392A Division JP6814304B2 (ja) | 2017-02-06 | 2018-02-05 | Hiv阻害剤化合物 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021016635A Division JP7282112B2 (ja) | 2017-02-06 | 2021-02-04 | Hiv阻害剤化合物 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2021046422A JP2021046422A (ja) | 2021-03-25 |
JP2021046422A5 true JP2021046422A5 (ja) | 2021-05-06 |
JP7105853B2 JP7105853B2 (ja) | 2022-07-25 |
Family
ID=61244746
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019542392A Active JP6814304B2 (ja) | 2017-02-06 | 2018-02-05 | Hiv阻害剤化合物 |
JP2020200176A Active JP7105853B2 (ja) | 2017-02-06 | 2020-12-02 | Hiv阻害剤化合物 |
JP2021016635A Active JP7282112B2 (ja) | 2017-02-06 | 2021-02-04 | Hiv阻害剤化合物 |
JP2022140748A Pending JP2022172294A (ja) | 2017-02-06 | 2022-09-05 | Hiv阻害剤化合物 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019542392A Active JP6814304B2 (ja) | 2017-02-06 | 2018-02-05 | Hiv阻害剤化合物 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021016635A Active JP7282112B2 (ja) | 2017-02-06 | 2021-02-04 | Hiv阻害剤化合物 |
JP2022140748A Pending JP2022172294A (ja) | 2017-02-06 | 2022-09-05 | Hiv阻害剤化合物 |
Country Status (34)
Country | Link |
---|---|
US (4) | US10294234B2 (ja) |
EP (2) | EP3577110B1 (ja) |
JP (4) | JP6814304B2 (ja) |
KR (3) | KR102547909B1 (ja) |
CN (3) | CN110536889B (ja) |
AR (1) | AR110922A1 (ja) |
AU (3) | AU2018215546B2 (ja) |
BR (1) | BR102018002152A8 (ja) |
CA (1) | CA3051588C (ja) |
CL (1) | CL2019002204A1 (ja) |
CO (1) | CO2019008531A2 (ja) |
CR (1) | CR20190354A (ja) |
CY (1) | CY1124276T1 (ja) |
DK (1) | DK3577110T3 (ja) |
DO (1) | DOP2019000201A (ja) |
EA (1) | EA201991684A1 (ja) |
ES (1) | ES2877595T3 (ja) |
HR (1) | HRP20210732T1 (ja) |
HU (1) | HUE054690T2 (ja) |
IL (1) | IL268282B2 (ja) |
JO (1) | JOP20180009A1 (ja) |
LT (1) | LT3577110T (ja) |
MX (2) | MX2019009212A (ja) |
MY (1) | MY200608A (ja) |
PE (1) | PE20191260A1 (ja) |
PH (1) | PH12019501786A1 (ja) |
PL (1) | PL3577110T3 (ja) |
PT (1) | PT3577110T (ja) |
SG (1) | SG11201907058TA (ja) |
SI (1) | SI3577110T1 (ja) |
TW (3) | TWI794629B (ja) |
UA (1) | UA123298C2 (ja) |
UY (1) | UY37592A (ja) |
WO (1) | WO2018145021A1 (ja) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6205354B2 (ja) | 2011-07-06 | 2017-09-27 | ギリアード サイエンシーズ, インコーポレイテッド | Hivの処置のための化合物 |
PE20190910A1 (es) | 2016-08-19 | 2019-06-26 | Gilead Sciences Inc | Compuestos terapeuticos utiles para el tratamiento profilactico o terapeutico de una infeccion por el virus del vih |
JOP20180009A1 (ar) * | 2017-02-06 | 2019-01-30 | Gilead Sciences Inc | مركبات مثبط فيروس hiv |
AR112412A1 (es) * | 2017-08-17 | 2019-10-23 | Gilead Sciences Inc | Formas de sal de colina de un inhibidor de la cápside del vih |
AR112413A1 (es) * | 2017-08-17 | 2019-10-23 | Gilead Sciences Inc | Formas sólidas de un inhibidor de la cápside del vih |
WO2019161017A1 (en) | 2018-02-15 | 2019-08-22 | Gilead Sciences, Inc. | Pyridine derivatives and their use for treating hiv infection |
CA3175557A1 (en) | 2018-02-16 | 2019-08-22 | Gilead Sciences, Inc. | Methods and intermediates for preparing a therapeutic compound useful in the treatment of retroviridae viral infection |
WO2020018459A1 (en) | 2018-07-16 | 2020-01-23 | Gilead Sciences, Inc. | Capsid inhibitors for the treatment of hiv |
TWI829205B (zh) * | 2018-07-30 | 2024-01-11 | 美商基利科學股份有限公司 | 抗hiv化合物 |
WO2020197991A1 (en) | 2019-03-22 | 2020-10-01 | Gilead Sciences, Inc. | Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use |
EP4065116A1 (en) | 2019-11-26 | 2022-10-05 | Gilead Sciences, Inc. | Capsid inhibitors for the prevention of hiv |
AU2021237718B2 (en) | 2020-03-20 | 2023-09-21 | Gilead Sciences, Inc. | Prodrugs of 4'-C-substituted-2-halo-2'-deoxyadenosine nucleosides and methods of making and using the same |
EP4153181A1 (en) | 2020-05-21 | 2023-03-29 | Gilead Sciences, Inc. | Pharmaceutical compositions comprising bictegravir |
WO2021262990A1 (en) | 2020-06-25 | 2021-12-30 | Gilead Sciences, Inc. | Capsid inhibitors for the treatment of hiv |
TWI815194B (zh) | 2020-10-22 | 2023-09-11 | 美商基利科學股份有限公司 | 介白素2-Fc融合蛋白及使用方法 |
CN116437958A (zh) | 2020-11-11 | 2023-07-14 | 吉利德科学公司 | 鉴定对采用gp120 CD4结合位点导向的抗体的疗法敏感的HIV患者的方法 |
TW202237146A (zh) * | 2021-01-25 | 2022-10-01 | 美商布里生物科學股份有限公司 | 使用腺苷衍生物及衣殼抑制劑之hiv組合療法 |
WO2023102523A1 (en) | 2021-12-03 | 2023-06-08 | Gilead Sciences, Inc. | Therapeutic compounds for hiv virus infection |
CA3237155A1 (en) | 2021-12-03 | 2023-06-08 | Zhimin Du | Therapeutic compounds for hiv virus infection |
US11787825B2 (en) | 2021-12-03 | 2023-10-17 | Gilead Sciences, Inc. | Therapeutic compounds for HIV virus infection |
TW202400172A (zh) | 2022-04-06 | 2024-01-01 | 美商基利科學股份有限公司 | 橋聯三環胺甲醯基吡啶酮化合物及其用途 |
WO2024044477A1 (en) | 2022-08-26 | 2024-02-29 | Gilead Sciences, Inc. | Dosing and scheduling regimen for broadly neutralizing antibodies |
CN115215803B (zh) * | 2022-09-19 | 2022-12-30 | 苏州美诺医药科技有限公司 | 一种4-卤代-1-(二氟甲基)-1h-咪唑的制备方法 |
WO2024076915A1 (en) | 2022-10-04 | 2024-04-11 | Gilead Sciences, Inc. | 4'-thionucleoside analogues and their pharmaceutical use |
Family Cites Families (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
DE2847064A1 (de) * | 1978-10-28 | 1980-05-08 | Boehringer Mannheim Gmbh | Verwendung von 2-cyanaziridinen als therapeutica bei strahlenschaeden |
US4326525A (en) | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
US5364620A (en) | 1983-12-22 | 1994-11-15 | Elan Corporation, Plc | Controlled absorption diltiazem formulation for once daily administration |
US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
US5001139A (en) | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
US4902514A (en) | 1988-07-21 | 1990-02-20 | Alza Corporation | Dosage form for administering nilvadipine for treating cardiovascular symptoms |
DE59207226D1 (de) | 1991-07-03 | 1996-10-31 | Ciba Geigy Ag | Pharmakologisch wirksame Hydrazinderivate und Verfahren zu deren Herstellung |
US5753652A (en) | 1991-07-03 | 1998-05-19 | Novartis Corporation | Antiretroviral hydrazine derivatives |
AU2003200066B9 (en) | 1992-03-11 | 2007-02-15 | Narhex Limited | Amine Derivatives of Oxo- and Hydroxy-substituted Hydrocarbons |
RU2126794C1 (ru) | 1992-03-11 | 1999-02-27 | Нархекс Лимитед | Аминопроизводные оксо- или гидроксизамещенных гидразинов, способ их получения и фармацевтические композиции для ингибирования ретровирусной протеазы |
DE59303870D1 (de) | 1992-12-23 | 1996-10-24 | Ciba Geigy Ag | Antiretrovirale hydrazinderivate |
US5461067A (en) | 1993-02-25 | 1995-10-24 | Abbott Laboratories | Retroviral protease inhibiting compounds |
DE69621651T2 (de) | 1995-11-21 | 2002-11-21 | Novartis Ag | Azahexan-derivate als substratisostere von retroviralen aspartat-proteasen |
US5849911A (en) * | 1996-04-22 | 1998-12-15 | Novartis Finance Corporation | Antivirally active heterocyclic azahexane derivatives |
TW409125B (en) | 1996-04-22 | 2000-10-21 | Novartis Ag | Antivirally active heterocyclic azahexane derivatives |
AU2959397A (en) | 1996-05-31 | 1998-01-05 | Novartis Ag | Process for the preparation of hydrazine derivatives useful as intermediates for the preparation of peptide analogues |
WO1998003476A1 (en) | 1996-07-17 | 1998-01-29 | Novartis Ag | Anilinopeptide derivatives |
CH694251A5 (de) | 1999-07-14 | 2004-10-15 | Eprova Ag | Herstellung von Tetrahydropterin und Derivaten. |
ATE401298T1 (de) | 1999-12-23 | 2008-08-15 | Ampac Fine Chemicals Llc | Verbessertes verfahren zur herstellung von 2s,3s- n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)- - nitrobenzenesulfonylamid hydrochlorid und anderen derivaten von 2-hydroxy-1,3-diamin |
CA2448084A1 (en) | 2001-05-22 | 2002-11-28 | Elan Pharmaceuticals, Inc. | Aza hydroxylated ethyl amine compounds |
EP1423167A1 (en) | 2001-08-28 | 2004-06-02 | Elan Pharmaceuticals, Inc. | Method for treating alzheimer's disease using quinaldoyl-amine derivatives of oxo- and hydroxy-substituted hydrocarbons |
US7157489B2 (en) | 2002-03-12 | 2007-01-02 | The Board Of Trustees Of The University Of Illinois | HIV protease inhibitors |
SG182849A1 (en) | 2003-04-25 | 2012-08-30 | Gilead Sciences Inc | Antiviral phosphonate analogs |
WO2005061487A1 (en) | 2003-12-11 | 2005-07-07 | Abbott Laboratories | Hiv protease inhibiting compounds |
US20050131017A1 (en) | 2003-12-11 | 2005-06-16 | Degoey David A. | HIV protease inhibiting compounds |
WO2006014282A2 (en) | 2004-07-06 | 2006-02-09 | Abbott Laboratories | Prodrugs of hiv protease inhibitors |
EP2258376B1 (en) | 2004-07-27 | 2019-02-27 | Gilead Sciences, Inc. | Phosphonate analogs of HIV inhibitor compounds |
EA013520B1 (ru) | 2005-02-10 | 2010-06-30 | Медивир Аб | Ингибиторы протеазы вич |
AU2006262274A1 (en) | 2005-06-22 | 2007-01-04 | The Massachusetts Institute Of Technology | HIV-1 protease inhibitors |
GB0610242D0 (en) | 2006-05-23 | 2006-07-05 | Novartis Ag | Organic compounds |
JP5372751B2 (ja) * | 2006-07-21 | 2013-12-18 | ギリアード サイエンシーズ, インコーポレイテッド | Aza−ペプチドプロテアーゼ阻害剤 |
CA2657936C (en) * | 2006-07-21 | 2017-01-10 | Gilead Sciences, Inc. | Antiviral protease inhibitors |
WO2008111116A1 (ja) | 2007-03-09 | 2008-09-18 | Pioneer Corporation | Av複合編集装置、av処理装置およびプログラム |
CN101702908A (zh) | 2007-03-23 | 2010-05-05 | 麻萨诸塞州大学 | Hiv-1蛋白酶抑制剂 |
PL2003120T3 (pl) | 2007-06-12 | 2010-04-30 | Concert Pharmaceuticals Inc | Pochodne azapeptydu jako inhibitory proteazy HIV |
US8431608B2 (en) | 2007-08-17 | 2013-04-30 | Icagen Inc. | Heterocycles as potassium channel modulators |
US20090076097A1 (en) | 2007-09-14 | 2009-03-19 | Protia, Llc | Deuterium-enriched atazanavir |
EP2220046B1 (en) | 2007-11-16 | 2014-06-18 | Gilead Sciences, Inc. | Inhibitors of human immunodeficiency virus replication |
WO2009114151A1 (en) | 2008-03-12 | 2009-09-17 | Nektar Therapeutics | Oligomer-amino acid and olgomer-atazanavir conjugates |
WO2009136365A1 (en) | 2008-05-08 | 2009-11-12 | Ranbaxy Laboratories Limited | Process for the preparation of 3,4-epoxy-2-amino-1-substituted butane derivatives and intermediate compounds thereof |
TWI466735B (zh) | 2008-09-18 | 2015-01-01 | Gs Yuasa Int Ltd | 紫外線照射裝置 |
KR101687841B1 (ko) | 2008-12-09 | 2016-12-19 | 길리애드 사이언시즈, 인코포레이티드 | 톨-유사 수용체의 조절제 |
WO2010077317A2 (en) | 2008-12-17 | 2010-07-08 | Amplyx Pharmaceuticals, Inc. | Protease inhibitors |
US8338441B2 (en) | 2009-05-15 | 2012-12-25 | Gilead Sciences, Inc. | Inhibitors of human immunodeficiency virus replication |
EP2292589A1 (en) | 2009-09-02 | 2011-03-09 | IMTM GmbH | Novel multifunctional peptidase inhibitors, especially for medical use |
WO2011080562A1 (en) | 2009-12-29 | 2011-07-07 | Hetero Research Foundation | Novel aza-peptides containing 2,2-disubstituted cyclobutyl and/or substituted alkoxy benzyl derivatives as antivirals |
WO2011139637A1 (en) | 2010-05-03 | 2011-11-10 | Philadelphia Health & Education Corporation | Small-molecule modulators of hiv-1 capsid stability and methods thereof |
AP2013006706A0 (en) | 2010-07-02 | 2013-02-28 | Gilead Sciences Inc | Napht-2-ylacetic acid derivatives to treat AIDS |
CN103209963A (zh) | 2010-07-02 | 2013-07-17 | 吉里德科学公司 | 作为hiv抗病毒化合物的2-喹啉基-乙酸衍生物 |
JP6006211B2 (ja) | 2010-09-02 | 2016-10-12 | パーデュー・リサーチ・ファウンデーションPurdue Research Foundation | 3員環の縮合エーテルカルバメートおよびその使用 |
US9024038B2 (en) | 2010-12-27 | 2015-05-05 | Purdue Research Foundation | Compunds and methods for treating HIV |
WO2012092188A1 (en) | 2010-12-27 | 2012-07-05 | Ghosh Arun K | Hydrogen bond forming p1 ligands and methods for treating hiv |
WO2012092168A1 (en) | 2010-12-27 | 2012-07-05 | Purdue Research Foundation | Fused 6,5 bicyclic ring system p2 ligands, and methods for treating hiv |
ES2707997T3 (es) | 2011-04-21 | 2019-04-08 | Gilead Sciences Inc | Compuestos de benzotiazol y su uso farmacéutico |
WO2012170792A1 (en) | 2011-06-10 | 2012-12-13 | Concert Pharmaceuticals, Inc. | Atazanavir metabolite derivatives |
JP6205354B2 (ja) | 2011-07-06 | 2017-09-27 | ギリアード サイエンシーズ, インコーポレイテッド | Hivの処置のための化合物 |
CN102863512B (zh) | 2011-07-07 | 2016-04-20 | 上海泓博智源医药技术有限公司 | 抗病毒化合物 |
GB201119401D0 (en) | 2011-11-10 | 2011-12-21 | Ucb Pharma Sa | Therapeutic agents |
WO2013091096A1 (en) | 2011-12-20 | 2013-06-27 | Boehringer Ingelheim International Gmbh | Condensed triclyclic compounds as inhibitors of hiv replication |
WO2013106781A1 (en) | 2012-01-12 | 2013-07-18 | Gan Daniel L | Eversible candle holder |
JP5911638B2 (ja) | 2012-04-20 | 2016-04-27 | ギリアード サイエンシーズ, インコーポレイテッド | ベンゾチアゾール−6−イル酢酸誘導体およびhiv感染を処置するためのそれらの使用 |
MD4736C1 (ro) | 2012-12-21 | 2021-07-31 | Gilead Sciences, Inc. | Compus policiclic de carbamoilpiridonă şi utilizarea farmaceutică a acestuia |
AR094311A1 (es) | 2012-12-27 | 2015-07-22 | Japan Tobacco Inc | Derivados de tetrahidroespiro-ciclopropil-pirido[1,2-a]pirazina inhibidores de la integrasa del hiv |
WO2014127052A1 (en) * | 2013-02-13 | 2014-08-21 | Zondlo Neal | Perfluoro-tert-butyl hydroxyproline |
WO2015097667A2 (en) | 2013-12-23 | 2015-07-02 | Cellworks Group, Inc., | A composition, process of preparation of said composition, kit and a method of treating cancer |
WO2015175704A1 (en) * | 2014-05-14 | 2015-11-19 | The Regents Of The University Of California | Inhibitors of bacterial dna gyrase with efficacy against gram-negative bacteria |
WO2015175994A1 (en) | 2014-05-16 | 2015-11-19 | Ghosh Arun K | Hiv-1 protease inhibitors and uses thereof |
PT3186239T (pt) | 2014-08-29 | 2019-01-10 | Gilead Sciences Inc | Agentes antirretrovirais |
EP3515897B1 (en) | 2016-09-19 | 2021-08-18 | H. Lundbeck A/S | Piperazine carbamates as modulators of magl and/or abhd6 and their use |
JOP20180009A1 (ar) | 2017-02-06 | 2019-01-30 | Gilead Sciences Inc | مركبات مثبط فيروس hiv |
TWI829205B (zh) | 2018-07-30 | 2024-01-11 | 美商基利科學股份有限公司 | 抗hiv化合物 |
-
2017
- 2017-02-06 JO JOP/2018/0009A patent/JOP20180009A1/ar unknown
-
2018
- 2018-01-31 BR BR102018002152A patent/BR102018002152A8/pt active Search and Examination
- 2018-02-02 UY UY0001037592A patent/UY37592A/es not_active Application Discontinuation
- 2018-02-02 AR ARP180100247A patent/AR110922A1/es unknown
- 2018-02-05 AU AU2018215546A patent/AU2018215546B2/en active Active
- 2018-02-05 CN CN201880023198.1A patent/CN110536889B/zh active Active
- 2018-02-05 JP JP2019542392A patent/JP6814304B2/ja active Active
- 2018-02-05 SI SI201830292T patent/SI3577110T1/sl unknown
- 2018-02-05 KR KR1020227027022A patent/KR102547909B1/ko active Application Filing
- 2018-02-05 LT LTEP18706072.8T patent/LT3577110T/lt unknown
- 2018-02-05 KR KR1020197025847A patent/KR102430812B1/ko active IP Right Grant
- 2018-02-05 EP EP18706072.8A patent/EP3577110B1/en active Active
- 2018-02-05 DK DK18706072.8T patent/DK3577110T3/da active
- 2018-02-05 PT PT187060728T patent/PT3577110T/pt unknown
- 2018-02-05 MY MYPI2019004469A patent/MY200608A/en unknown
- 2018-02-05 WO PCT/US2018/016893 patent/WO2018145021A1/en active Application Filing
- 2018-02-05 EA EA201991684A patent/EA201991684A1/ru unknown
- 2018-02-05 CA CA3051588A patent/CA3051588C/en active Active
- 2018-02-05 CN CN202210907879.2A patent/CN115093421A/zh active Pending
- 2018-02-05 HU HUE18706072A patent/HUE054690T2/hu unknown
- 2018-02-05 CR CR20190354A patent/CR20190354A/es unknown
- 2018-02-05 CN CN202211475398.5A patent/CN115991708A/zh active Pending
- 2018-02-05 TW TW109126112A patent/TWI794629B/zh active
- 2018-02-05 UA UAA201909440A patent/UA123298C2/uk unknown
- 2018-02-05 SG SG11201907058TA patent/SG11201907058TA/en unknown
- 2018-02-05 TW TW107103968A patent/TWI701243B/zh active
- 2018-02-05 EP EP21165835.6A patent/EP3909949A1/en active Pending
- 2018-02-05 US US15/888,749 patent/US10294234B2/en active Active
- 2018-02-05 PL PL18706072T patent/PL3577110T3/pl unknown
- 2018-02-05 KR KR1020237021040A patent/KR20230097222A/ko not_active Application Discontinuation
- 2018-02-05 ES ES18706072T patent/ES2877595T3/es active Active
- 2018-02-05 MX MX2019009212A patent/MX2019009212A/es unknown
- 2018-02-05 PE PE2019001536A patent/PE20191260A1/es unknown
- 2018-02-05 TW TW112103166A patent/TW202344506A/zh unknown
-
2019
- 2019-03-26 US US16/364,487 patent/US10752636B2/en active Active
- 2019-07-25 IL IL268282A patent/IL268282B2/en unknown
- 2019-08-02 MX MX2022012616A patent/MX2022012616A/es unknown
- 2019-08-05 DO DO2019000201A patent/DOP2019000201A/es unknown
- 2019-08-05 PH PH12019501786A patent/PH12019501786A1/en unknown
- 2019-08-05 CO CO2019008531A patent/CO2019008531A2/es unknown
- 2019-08-05 CL CL2019002204A patent/CL2019002204A1/es unknown
-
2020
- 2020-03-02 US US16/805,933 patent/US11078208B1/en active Active
- 2020-11-04 AU AU2020264300A patent/AU2020264300B2/en active Active
- 2020-12-02 JP JP2020200176A patent/JP7105853B2/ja active Active
-
2021
- 2021-02-04 JP JP2021016635A patent/JP7282112B2/ja active Active
- 2021-04-07 US US17/224,557 patent/US20230027055A1/en active Pending
- 2021-05-11 HR HRP20210732TT patent/HRP20210732T1/hr unknown
- 2021-06-30 CY CY20211100584T patent/CY1124276T1/el unknown
-
2022
- 2022-09-05 JP JP2022140748A patent/JP2022172294A/ja active Pending
- 2022-11-19 AU AU2022271510A patent/AU2022271510A1/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2021046422A5 (ja) | ||
JP4981683B2 (ja) | アルコール溶媒中での有機フルオロ化合物の調製方法 | |
JP5902774B2 (ja) | スコピンエステルを調製するための新規プロセス | |
US20160009827A1 (en) | An Improved Process for Preparation of Sugammadex Sodium | |
JP2005500988A5 (ja) | ||
JP2010527371A5 (ja) | ||
JP5822831B2 (ja) | チオトロピウム臭化物の無水物 | |
CA2769395A1 (en) | Method for producing a radioactively marked peptide | |
US20180362588A1 (en) | Process for the manufacture of degarelix and its intermediates | |
JP2008544975A5 (ja) | ||
EP3138851A1 (en) | Quaternary assemblies of water-soluble non-peptide helical foldamers, their use and production thereof | |
KR20170023417A (ko) | L-카르노신 아연 착물의 제조 방법 | |
WO2011116686A1 (zh) | 西他列汀中间体及制备方法和用途 | |
JP7460521B2 (ja) | シクロデキストリン誘導体の合成のための方法 | |
US8076499B2 (en) | Method for preparing precursor of radioactive 3-iodobenzylguanidine | |
JP2008524327A5 (ja) | ||
JP2750355B2 (ja) | 3−エキソメチレンセファム誘導体の製造法 | |
US20140005355A1 (en) | Process for preparation of caspofungin acetate and intermediates | |
JP2005516962A5 (ja) | ||
JP2895959B2 (ja) | スルホニウム塩の製造方法 | |
JP2020514373A5 (ja) | ||
CN109734615B (zh) | 替米沙坦中间体4-氨基-3-甲基苯甲酸的合成方法 | |
WO2006128688B1 (en) | Process for the preparation of pramipexole | |
JP2960704B2 (ja) | アミン類およびジアミン類の合成方法 | |
WO2010091277A2 (en) | Solid state forms of aliskiren compounds |